Sonoma Pharmaceuticals, Inc.
SNOA· Nasdaq
Filed Feb 12, 2015 · 10-Q · 43 days after period end · 0001019687-15-000568
| Metric | Q3 2015 | Q3 2014 | Q3 2010 |
|---|---|---|---|
| Revenue | $3.22M | $3.29M | $2.31M |
| Net Income | -$5.91M | -$611.00K | -$2.23M |
| EPS Diluted | -$0.69 | -$0.09 | -$0.08 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sonoma Pharmaceuticals, Inc. · CIK 1367083 · Engraved from SEC EDGAR
ended Dec 31, 2014 · filed Feb 12, 2015 · 43 d after period end